Related Experiment Video
Updated: May 1, 2026

05:34
Isolation and Culturing of Primary Murine Adipocytes from Lean and Obese Mice
Published on: January 24, 2025
2.9K
Gene expression differences in adipose tissue associated with breast tumorigenesis.
Lori A Sturtz1, Brenda Deyarmin1, Ryan van Laar2
1Windber Research Institute; Windber, PA USA.
Adipocyte
|April 11, 2014
Summary
Adipose tissue, once thought inert, actively influences breast cancer. Tumor-adjacent fat shows heightened immune responses and gene expression promoting tumor growth, invasion, and angiogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Adipose tissue's role in breast tumorigenesis is understudied, despite rising obesity and fat grafting procedures.
- Understanding adipose tissue's impact on tumor etiology is critical for breast cancer research.
Purpose of the Study:
- To investigate molecular differences in adipose tissue related to breast tumor presence and proximity.
- To determine if adipose tissue actively contributes to the breast tumor microenvironment.
Main Methods:
- Laser microdissection of adipose tissue from post-menopausal women with invasive breast tumors or non-malignant diagnoses.
- Gene expression profiling using microarrays.
- Pathway analysis to identify differential gene expression patterns.
Main Results:
- Significant differences in immune response pathways were observed between non-malignant, distant, and tumor-adjacent adipose tissue.
- Adipose tissue near tumors showed increased expression of genes linked to proliferation, invasion, and angiogenesis (e.g., SPP1, RRM2, MMP9).
- Tumor-adjacent adipose tissue exhibited heightened immunotolerance, with increased expression of anti-inflammatory genes (e.g., MARCO, VSIG4).
Conclusions:
- Adipose tissue molecular profiles vary based on tumor proximity, indicating an active role in breast tumorigenesis.
- Heightened immunotolerance in adipose tissue creates a microenvironment conducive to tumor development.
- Adipose tissue is not inert but actively participates in breast cancer progression.

